Gurleen Saini, MS

Sr. Principal Scientist
Boehringer Ingelheim
Ridgefield, Connecticut

Gurleen Saini, Sr. Principal Scientist in CPS Global DMPK at Boehringer Ingelheim (Bioanalysis US), serves as the Neutralizing Anti-Drug Antibodies (nAb) Laboratory Lead.
In this role, she is responsible for defining bioanalytical strategies and leading assay development for the detection of neutralizing anti-drug antibodies. Her work includes immunogenicity assessment, scientific consultation, and providing regulatory guidance to support the advancement of compounds across all clinical phases (Phase 1–4) as part of global regulatory submissions.

Disclosure information not submitted.

Presentation(s):

• Beyond the Template: Flexible Neutralizing Antibody (nAb) Assessment in the Era of Emerging Modalities and Complex Mechanisms of Action

  Wednesday, July 15, 2026
  9:35 AM - 10:05 AM East Coast USA Time